NCT07023991View on ClinicalTrials.gov

Dexmedetomidine Added to Bupivacaine for ESP Block in Children Undergoing Lower Abdominal Surgeries

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Post-operative Pain
Interventions
DRUG

Bupivacaine

Bupivacaine will be used in an ESP block to provide postoperative analgesia.

DRUG

Dexmedetomidine

Dexmedetomidine will be added to bupivacaine in the ESP block to evaluate its effect on duration of postoperative analgesia.

Trial Locations (1)

11865

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER